logo
Celsius breaks silence over link between its drinks and cocaine

Celsius breaks silence over link between its drinks and cocaine

Daily Mail​6 hours ago

Celsius has finally addressed claims that its popular energy drinks can cause false positives for cocaine in drug tests.
The controversy began on June 8 when a Detroit Tigers sports reporter tweeted that Major League Baseball (MLB) teams were advising players to avoid the drink.
'Celsius has an ingredient known to flag as cocaine in MLB drug testing, and although it's not officially banned, it's strongly discouraged,' the reporter wrote in a now-deleted X post.
The drink maker has dismissed these comments, stating: 'Claims that Celsius could cause someone to fail a drug test have been proven false, and there is no merit to these claims.'
The claims went viral online, prompting a response from the MLB drug watchdog, which also said the claims were untrue.
However, it comes at a time when Americans are increasingly concerned about ingredients in their food and drinks.
Celsius beverages contain about 1,810 milligrams of taurine, far exceeding the typical daily intake of 40 to 400 milligrams.
Taurine is an amino sulfonic acid that may promote the growth of bacteria associated with colorectal cancer, which are often more abundant in affected individuals' guts.
While there was no scientific evidence to support the notion that Celsius ingredients could be read as cocaine in a drug test, the post quickly spread across social media, likely due to how popular Celsius has become in the US.
Celsius is the third-largest energy drink company in the nation, following Monster and Red Bull.
But the MLB's product certifier was quick to deem the claims false.
'We are not aware of any specific ingredient in Celsius that would cause a positive drug test result, nor have we communicated such concerns to any MLB club or player,' the National Sanitation Foundation (NSF) said last week.
Celsius contains common energy drink ingredients like caffeine, green tea extract and guarana seed extract, as well as artificial sweeteners.
These are not classified as banned substances, and there is no scientific evidence that they can trigger a false positive for the narcotic.
However, Celsius is not on the list of certified energy drinks for professional athletes.
Beverages including C4 and Red Bull do carry the NSF certification and are commonly recommended to athletes.
Obtaining NSF Certified for Sport status involves rigorous testing, including lot-by-lot analysis for banned substances, label accuracy and manufacturing audits.
Celsius may not have pursued this certification due to the significant cost, time and effort required, especially if their target market includes non-athlete consumers who do not prioritize NSF certification.
The National Collegiate Athletic Association (NCAA) has not banned Celsius, though it does enforce strict limits on caffeine intake for student athletes.
'Some collegiate athletes may have questions about whether one ingredient in CELSIUS products, caffeine derived from guarana extract, raises any issues under NCAA rules,' Celsius stated on its website.
NCAA states that a urine caffeine concentration above 15 micrograms per milliliter will trigger a positive result, typically the equivalent of consuming 500 milligrams of caffeine within a few hours of competition.
A single can of Celsius contains 200 to 270 milligrams of caffeine, meaning two cans consumed in a short time frame could easily exceed the NCAA threshold.
These limits are in place to reduce health risks from excessive stimulant use, including jitteriness, rapid heart rate and dehydration.
Celsius energy drinks contain guarana (a concentrated source of caffeine), taurine and L-carnitine, none of which are banned by the NCAA or US Anti-Doping Agency (USADA).
A 12-ounce can of Celsius typically contains about two eight-ounce cups of coffee.
The FDA recommends healthy adults limit caffeine to 400 milligrams daily (roughly two cans of Celsius), but individual sensitivity varies.
For some, even one can may cause jitters or other effects. Caffeine's half-life of three to five hours means repeated consumption can lead to accumulation.
Celsius has faced a class-action lawsuit over alleged misbranding, such as misleading claims about preservatives.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Common pregnancy complication linked to childhood seizures
Common pregnancy complication linked to childhood seizures

The Independent

time11 minutes ago

  • The Independent

Common pregnancy complication linked to childhood seizures

A new study by University of Iowa Health Care researchers has found that gestational hypertension, which affects about 16 per cent of US pregnancies, is associated with an increased risk of seizures in children. The study, published in the Journal of Clinical Investigation, utilized clinical databases containing over 246 million patients and lab mice studies. Researchers found that children born to mothers with high blood pressure during pregnancy had significantly higher rates of seizures. Mice testing confirmed increased seizure sensitivity and death due to seizures in offspring exposed to gestational hypertension in the womb. The study also indicated that male offspring were more vulnerable and that brain inflammation played a significant role in the disease process, suggesting it may also do so in human children.

Shohei Ohtani hit with huge news over gambling scandal hours before return to the mound with LA Dodgers
Shohei Ohtani hit with huge news over gambling scandal hours before return to the mound with LA Dodgers

Daily Mail​

time14 minutes ago

  • Daily Mail​

Shohei Ohtani hit with huge news over gambling scandal hours before return to the mound with LA Dodgers

Shohei Ohtani's disgraced former interpreter, Ippei Mizuhara, has reported to a federal prison in Pennsylvania to begin his incarceration. Mizuhara will serve 57 months in Federal Correctional Institution Allenwood Low, a low-security facility in the rural part of the state, after stealing around $17million from the Los Angeles Dodgers megastar. The news of Ohtani's former interpreter comes hours before the Japanese dynamo is slated to make his first start as a pitcher since August 2023. Mizuhara was fired by the Dodgers last March after it was revealed millions in wire transfers from Ohtani's bank accounts were sent to an illegal bookmaker. The 40-year-old pled guilty to bank fraud and filing a false tax return last June, with his report to prison coming one year after he formally admitted to the crimes, per ESPN. Miuzhara revealed he placed over 19,000 bets over a 2-year span and had amassed more than $40million in debt.

Second patient death reported with gene therapy for muscular dystrophy
Second patient death reported with gene therapy for muscular dystrophy

The Independent

time21 minutes ago

  • The Independent

Second patient death reported with gene therapy for muscular dystrophy

Shares of Sarepta Therapeutics plunged Monday after the biotech drugmaker reported a second death in connection with its gene therapy for muscular dystrophy. Sarepta reported the death over the weekend and provided additional details about its response, which includes pausing shipments of the therapy, Elevidys, for older patients who are no longer able to walk. The one-time treatment is approved for children with a genetic variant of Duchenne's muscular dystrophy, which causes weakness, loss of mobility and early death in males. Elevidys is the first gene therapy approved in the U.S. for the rare muscle-wasting condition, but it has faced scrutiny since its accelerated approval in 2023. The second death, like an earlier one reported in March, occurred in a teenage boy who suffered a fatal case of acute liver injury, a known side effect of the therapy. Older patients receive a larger dose of the therapy. Sarepta said it would pause a study in those patients and assemble an expert panel to recommend new safety protocols for taking the drug. Those changes are expected to include increased use of immune-system suppressing drugs, company executives said Monday. The liver injury associated with the therapy is thought to be connected to the immune system's response. Sarepta said it was cooperating with the Food and Drug Administration, which would have to sign off on any changes to the product's use. Elevidys received expedited approval despite concerns from some FDA scientists about its effectiveness in treating Duchenne's. The FDA granted full approval last year and expanded the therapy's use to patients 4 years and older, regardless of whether they are still able to walk. Previously it was only available for younger patients who were still walking. Shares of the Cambridge, Massachusetts-based company fell more than 42% to close at about $21 in trading. Wall Street analysts speculated that FDA officials, including new vaccine chief Dr. Vinay Prasad, might impose more restrictions on the drug or even block its use. Prasad has been highly critical of the therapy since its approval under the agency's previous leadership. 'Now with two deaths reported in this segment of the market, it seems incrementally more possible that the FDA could step in and remove the therapy from the market in non-ambulatory patients,' said Leerink Partners analyst Joseph Schwartz, in a Sunday research note. Elevidys uses a disabled virus to insert a replacement gene for producing dystrophin into patient cells. It costs $3.2 million for a one-time infusion. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store